Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-𝛽1) in Patients with Gastric Cancer

Table 4

Number and proportion (%) of studied cases with elevated serum levels of immunosuppressive cytokines (IL-10, TGF-𝛽1), as related to stage of gastric cancer.

Gastric cancer staging	No. of patients	No. (%) of patients with elevated level of immunosuppressive cytokine
		IL-10 only	TGF-𝛽1 only	IL10  +  TGF-𝛽1
Stage I-II	14	2 (14.3%)	7 (50%)	2 (14.3%)
Stage III-IV	28	6 (21.4%)	11 (39.3%)	11 (39.3%)